6th Annual Washington University Inflammatory Bowel Disease Center Multidisciplinary Conference 2024
$20,00
This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!
Include: 19 videos, size: 4.69 GB
Washington University School of Medicine in St. Louis 6th Annual Washington University Inflammatory Bowel Disease Center Multidisciplinary Conference 2024
Include: 19 videos, size: 4.69 GB
Target Audience: gastroenterologists, internists, surgeons
Information:
Presented By
Inflammatory Bowel Diseases Center, Division of Gastroenterology
Washington University School of Medicine in St. Louis
Credit Provided By
Washington University School of Medicine in St. Louis, Continuing Medical Education
6th Annual Washington University Inflammatory Bowel Disease Center Multidisciplinary Conference is planned and implemented by physicians and nurses. This activity is designed for gastroenterologists, internists, surgeons, and nurses to give updates and updated approaches to treatment of patients with inflammatory bowel diseases. It may also be of interest to nutritionists and physician associates. This 8 hour Live course will provide education through lectures, case studies and question & answer sessions. The activity will highlight best practice across inflammatory bowel diseases. The goal of this activity is enhanced knowledge, skills/strategy and performance.
The intended result of this activity is increase knowledge, competence, performance and skill and enhanced patient care. At the completion of the activity, registrants should be able to:
- Describe the role of new and emerging therapies for inflammatory bowel disease.
- Summarize new insights into the investigation of inflammatory bowel diseases and complications associated with these diseases.
- Implement new paradigms and algorithms in the evaluation and management of inflammatory bowel disease.
Topics:
- Balancing benefits versus risks of Janus Kinase inhibitors in the management of IBD.mp4
- Case discussion in the Management of IBD in a patient with concurrent Uveitis.mp4
- Case Discussion in the Management of IBD in Women of Child-Bearing Age Group.mp4
- Case studies – IBD, radiology, surgery.mp4
- Current and aspirational treatment targets in IBD.mp4
- Debate – Approach to symptomatic stricturing CD- Endoscopic vs surgical approaches.mp4
- Debate- 1st line therapy in Ulcerative colitis- Anti-TNF vs a non-anti-TNF agent.mp4
- Dermatological manifestations in an IBD patient IBD-associated refractory presentations, treatment-related paradoxical.mp4
- Keynote Translational approaches to new drugs and drug delivery to break the therapeutic ceiling.mp4
- Keynote- Perianal Crohn’s disease- Optimizing the management with the patient as the central focus.mp4
- Liver disease in IBD overlap autoimmune diseases and related comobidities.mp4
- Newer and older Leukocyte anti-trafficking molecules in the management of IBD.mp4
- Non-invasive monitoring of disease activity in IBD- Current and promising approaches.mp4
- Positioning of current medical therapies in the management of Crohn’s disease.mp4
- Q&A Approaches to Fistulizing Crohn’s disease.mp4
- Q&A Approaching the Complications of IBD.mp4
- Q&A Optimizing the Current Targets in treatment of IBD.mp4
- Q&A Updates in the Medical Management of Inflammatory Bowel Diseases (IBD).mp4
- Role of anti-IL-23 and anti-IL-12 23 agents in the management of IBD.mp4
Related products
